Lomustine-temozolomide combination efficacious in newly diagnosed glioblastoma

被引：4
|
作者：
Killock, David
机构：
[1] Nature Reviews Clinical Oncology,
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2019年 / 16卷 / 05期
关键词：
D O I：
10.1038/s41571-019-0192-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [1] Lomustine–temozolomide combination efficacious in newly diagnosed glioblastoma
    David Killock
    Nature Reviews Clinical Oncology, 2019, 16 : 273 - 273
  • [2] Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
    Werner, Jan-Michael
    Weller, Johannes
    Ceccon, Garry
    Schaub, Christina
    Tscherpel, Caroline
    Lohmann, Philipp
    Bauer, Elena K.
    Schaefer, Niklas
    Stoffels, Gabriele
    Baues, Christian
    Celik, Eren
    Marnitz, Simone
    Kabbasch, Christoph
    Gielen, Gerrit H.
    Fink, Gereon R.
    Langen, Karl-Josef
    Herrlinger, Ulrich
    Galldiks, Norbert
    CLINICAL CANCER RESEARCH, 2021, 27 (13) : 3704 - 3713
  • [3] ASSESSMENT OF RESPONSE TO LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN ADDITION TO RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA USING FET PET
    Werner, Jan-Michael
    Wollring, Michael M.
    Tscherpel, Caroline
    Rosen, Elena K.
    Ceccon, Garry
    Stetter, Isabelle
    Lohmann, Philipp
    Weller, Johannes
    Stoffels, Gabriele
    Baues, Christian
    Celik, Eren
    Mottaghy, Felix M.
    Goldbrunner, Roland
    Herrlinger, Ulrich
    Fink, Gereon R.
    Langen, Karl-Josef
    Galldiks, Norbert
    NEURO-ONCOLOGY, 2024, 26
  • [4] ASSESSMENT OF RESPONSE TO LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN ADDITION TO RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA USING FET PET
    Werner, J.
    Wollring, M. M.
    Tscherpel, C.
    Rosen, E. K.
    Ceccon, G.
    Stetter, I
    Lohmann, P.
    Weller, J.
    Stoffels, G.
    Baues, C.
    Celik, E.
    Mottaghy, F. M.
    Goldbrunner, R.
    Herrlinger, U.
    Fink, G. R.
    Langen, K.
    Galldiks, N.
    NEURO-ONCOLOGY, 2024, 26 : V50 - V50
  • [5] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaros Lazaridis
    Niklas Schäfer
    Sarah Teuber-Hanselmann
    Tobias Blau
    Teresa Schmidt
    Christoph Oster
    Johannes Weller
    Theophilos Tzaridis
    Daniela Pierscianek
    Kathy Keyvani
    Christoph Kleinschnitz
    Martin Stuschke
    Björn Scheffler
    Cornelius Deuschl
    Ulrich Sure
    Ulrich Herrlinger
    Sied Kebir
    Martin Glas
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 787 - 792
  • [6] Combination Therapy of Lomustine and Temozolomide in Patients with newly diagnosed Glioblastoma with methylated MGMT Promotor
    Lenzen, Julia
    Feldmann, H. J.
    ONKOLOGE, 2019, 25 (12): : 1118 - 1120
  • [7] DIAGNOSIS OF PSEUDOPROGRESSION FOLLOWING RADIOTHERAPY PLUS LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS USING FET PET
    Werner, Jan-Michael
    Ceccon, Garry
    Weller, Johannes
    Schaub, Christina
    Tscherpel, Caroline
    Lohmann, Philipp
    Bauer, Elena
    Schaefer, Niklas
    Stoffels, Gabriele
    Kabbasch, Christoph
    Baues, Christian
    Marnitz, Simone
    Fink, Gereon R.
    Langen, Karl-Josef
    Herrlinger, Ulrich
    Galldiks, Norbert
    NEURO-ONCOLOGY, 2020, 22 : 152 - 153
  • [8] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaridis, Lazaros
    Schaefer, Niklas
    Teuber-Hanselmann, Sarah
    Blau, Tobias
    Schmidt, Teresa
    Oster, Christoph
    Weller, Johannes
    Tzaridis, Theophilos
    Pierscianek, Daniela
    Keyvani, Kathy
    Kleinschnitz, Christoph
    Stuschke, Martin
    Scheffler, Bjoern
    Deuschl, Cornelius
    Sure, Ulrich
    Herrlinger, Ulrich
    Kebir, Sied
    Glas, Martin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 787 - 792
  • [9] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Lazaridis, Lazaros
    Schaefer, Niklas
    Kebir, Sied
    Weller, Johannes
    Tzaridis, Theophilos-Dimitrios
    Scheffler, Bjoern
    Pierscianek, Daniela
    Kleinschnitz, Christoph
    Stuschke, Martin
    Sure, Ulrich
    Herrlinger, Ulrich
    Glas, Martin
    NEURO-ONCOLOGY, 2018, 20 : 119 - 120
  • [10] Combination of Tumor Treating Fields (TTFields) with lomustine (CCNU) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
    Lazaridis, L.
    Kebir, S.
    Weller, J.
    Tzaridis, T. -D
    Scheffler, B.
    Pierscianek, D.
    Kleinschnitz, C.
    Stuschke, M.
    Sure, U.
    Herrlinger, U.
    Schaefer, N.
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S109 - S109
12345